Stockhead on MSN
ASX Quarterly Health Wrap: Lumos lands US$317m deal as ReNerve and Vitrafy hit key milestones
In partnership with the U.S. Army Institute of Surgical Research (USAISR), Vitrafy began the second phase of its platelet ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...
During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...
Nearly half of all adults in the United States have either diabetes or prediabetes, yet more than 100 million, about ...
Charles Longshore distinctly remembers the tipping point that led his Alabama middle school to ban cell phones, two years ...
Archer Aviation CEO Adam Goldstein told Newsweek that he believes eVTOLs are safer, cheaper and quieter than helicopters.
The University of Dundee will host Scotland’s National Testing and Research Laboratory, a vital new instrument in the battle ...
The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and Human Services said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback